HGC Investment Management Inc. - EUCRATES BIOMEDICAL ACQU COR ownership

EUCRATES BIOMEDICAL ACQU COR's ticker is EUCRU and the CUSIP is G3141W114. A total of 18 filers reported holding EUCRATES BIOMEDICAL ACQU COR in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
HGC Investment Management Inc. ownership history of EUCRATES BIOMEDICAL ACQU COR
ValueSharesWeighting
Q4 2022$793
-99.9%
79,1500.0%0.04%
-35.2%
Q3 2022$794,000
-49.6%
79,150
-50.0%
0.05%
+12.5%
Q2 2022$1,575,000
+101.7%
158,300
+100.0%
0.05%
+2.1%
Q1 2022$781,00079,1500.05%
Other shareholders
EUCRATES BIOMEDICAL ACQU COR shareholders Q2 2022
NameSharesValueWeighting ↓
Altium Capital Management LP 400,000$4,005,0001.11%
Sio Capital Management, LLC 300,000$3,004,0000.61%
Wealthspring Capital LLC 117,054$1,177,0000.32%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,000,000$10,012,0000.21%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$2,012,0000.21%
Sage Mountain Advisors LLC 95,970$965,0000.20%
BVF INC/IL 500,000$5,030,0000.19%
HealthCor Management, L.P. 334,180$3,362,0000.12%
Verition Fund Management LLC 397,692$4,056,0000.05%
Rock Springs Capital Management LP 206,000$2,063,0000.04%
View complete list of EUCRATES BIOMEDICAL ACQU COR shareholders